Przewidywanie ciężkości COVID-19

• Julian
• 30 kwietnia, 202130 kwietnia, 2021
• 0

Przewidywanie ciężkości COVID-19 za pomocą swoistego przeciwciała nukleokapsydowego i wskaźnika czynnika ryzyka choroby 

Efficient strategies for predicting COVID-19 illness trajectories are urgently wanted. Right here, enzyme-linked immunosorbent assay (ELISA) and coronavirus antigen microarray (COVAM) evaluation mapped antibody epitopes within the plasma of COVID-19 sufferers (n = 86) experiencing a variety of illness states. The experiments recognized antibodies to a 21-residue epitope from nucleocapsid (termed Ep9) related to extreme illness, together with admission to the intensive care unit (ICU), requirement for ventilators, or demise.

Importantly, anti-Ep9 antibodies will be detected inside 6 days post-symptom onset and generally inside 1 day. Moreover, anti-Ep9 antibodies correlate with varied comorbidities and hallmarks of immune hyperactivity. We introduce a simple-to-calculate, illness threat issue rating to quantitate every affected person’s comorbidities and age. For sufferers with anti-Ep9 antibodies, scores above 3.Zero predict extra extreme illness outcomes with a 13.42 chance ratio (96.7% specificity).

The outcomes lay the groundwork for a brand new sort of COVID-19 prognostic to permit early identification and triage of high-risk sufferers. Such info might information more practical therapeutic intervention.IMPORTANCE The COVID-19 pandemic has resulted in over two million deaths worldwide. Regardless of efforts to struggle the virus, the illness continues to overwhelm hospitals with severely unwell sufferers.

Prognosis of COVID-19 is instantly completed by a mess of dependable testing platforms; nonetheless, prognostic prediction stays elusive. To this finish, we recognized a brief epitope from the SARS-CoV-2 nucleocapsid protein and likewise a illness threat issue rating primarily based upon comorbidities and age. The presence of antibodies particularly binding to this epitope plus a rating cutoff can predict extreme COVID-19 outcomes with 96.7% specificity.

IGF BP3 antibody
70R-IR022	Fitzgerald	50 ug	EUR 327.6
Description: Affinity purified Rabbit polyclonal IGF BP3 antibody

IGF BP5 antibody
70R-IR023	Fitzgerald	50 ug	EUR 327.6
Description: Affinity purified Rabbit polyclonal IGF BP5 antibody

IGF BP7 antibody
70R-IR024	Fitzgerald	50 ug	EUR 327.6
Description: Affinity purified Rabbit polyclonal IGF BP7 antibody

IGF BP2 protein
30R-AI105	Fitzgerald	20 ug	EUR 327.6
Description: Purified recombinant Human IGF BP2 protein

IGF BP6 protein
30R-AI106	Fitzgerald	25 ug	EUR 327.6
Description: Purified recombinant Human IGF BP6 protein

IGF BP7 protein
30R-AI120	Fitzgerald	25 ug	EUR 327.6
Description: Purified recombinant Human IGF BP7 protein

IGF BP1 protein
30R-AI121	Fitzgerald	25 ug	EUR 327.6
Description: Purified recombinant Human IGF BP1 protein

IGF BP3 protein
30R-AI122	Fitzgerald	25 ug	EUR 327.6
Description: Purified recombinant Human IGF BP3 protein

IGF BP5 protein
30R-AI124	Fitzgerald	25 ug	EUR 327.6
Description: Purified recombinant Human IGF BP5 protein

IGF-BP3, Human
HY-P7020	MedChemExpress	10ug	EUR 280.8

IGF-BP5, Human
HY-P7021	MedChemExpress	50ug	EUR 721.2

IGF-BP3, human
RC216-12B3	Bio Basic	5ug	EUR 125.26

IGF-1, Human
HY-P7018	MedChemExpress	10ug	EUR 129.6

IGF-2, Human
HY-P7019	MedChemExpress	100ug	EUR 432

IGF-1, human
RC216-12	Bio Basic	1mg	EUR 451.5

Antibody for Human IGF-1
SPC-699D-ALP	Stressmarq	0.1mg	EUR 472.8
Description: A polyclonal antibody for IGF-1 from Human | Mouse. The antibody is produced in rabbit after immunization with human synthetic peptide from the mid-protein of Human IGF-1. The Antibody is tested and validated for WB, ICC/IF, IHC assays with the following recommended dilutions: WB (1:1000); ICC/IF (1:100); IHC (1:50). This IGF-1 antibody is conjugated to Alkaline Phosphatase.

Antibody for Human IGF-1
SPC-699D-DY350	Stressmarq	0.1mg	EUR 496.8
Description: A polyclonal antibody for IGF-1 from Human | Mouse. The antibody is produced in rabbit after immunization with human synthetic peptide from the mid-protein of Human IGF-1. The Antibody is tested and validated for WB, ICC/IF, IHC assays with the following recommended dilutions: WB (1:1000); ICC/IF (1:100); IHC (1:50). This IGF-1 antibody is conjugated to Dylight 350.

Antibody for Human IGF-1
SPC-699D-DY405	Stressmarq	0.1mg	EUR 483.6
Description: A polyclonal antibody for IGF-1 from Human | Mouse. The antibody is produced in rabbit after immunization with human synthetic peptide from the mid-protein of Human IGF-1. The Antibody is tested and validated for WB, ICC/IF, IHC assays with the following recommended dilutions: WB (1:1000); ICC/IF (1:100); IHC (1:50). This IGF-1 antibody is conjugated to Dylight 405.

Antibody for Human IGF-1
SPC-699D-DY488	Stressmarq	0.1mg	EUR 471.6
Description: A polyclonal antibody for IGF-1 from Human | Mouse. The antibody is produced in rabbit after immunization with human synthetic peptide from the mid-protein of Human IGF-1. The Antibody is tested and validated for WB, ICC/IF, IHC assays with the following recommended dilutions: WB (1:1000); ICC/IF (1:100); IHC (1:50). This IGF-1 antibody is conjugated to Dylight 488.

Antibody for Human IGF-1
SPC-699D	Stressmarq	0.1mg	EUR 424.8
Description: A polyclonal antibody for IGF-1 from Human | Mouse. The antibody is produced in rabbit after immunization with human synthetic peptide from the mid-protein of Human IGF-1. The Antibody is tested and validated for WB, ICC/IF, IHC assays with the following recommended dilutions: WB (1:1000); ICC/IF (1:100); IHC (1:50). This IGF-1 antibody is unconjugated.

Antibody for Human IGF-1
SPC-699D-A390	Stressmarq	0.1mg	EUR 481.2
Description: A polyclonal antibody for IGF-1 from Human | Mouse. The antibody is produced in rabbit after immunization with human synthetic peptide from the mid-protein of Human IGF-1. The Antibody is tested and validated for WB, ICC/IF, IHC assays with the following recommended dilutions: WB (1:1000); ICC/IF (1:100); IHC (1:50). This IGF-1 antibody is conjugated to ATTO 390.

Antibody for Human IGF-1
SPC-699D-A488	Stressmarq	0.1mg	EUR 480
Description: A polyclonal antibody for IGF-1 from Human | Mouse. The antibody is produced in rabbit after immunization with human synthetic peptide from the mid-protein of Human IGF-1. The Antibody is tested and validated for WB, ICC/IF, IHC assays with the following recommended dilutions: WB (1:1000); ICC/IF (1:100); IHC (1:50). This IGF-1 antibody is conjugated to ATTO 488.

Antibody for Human IGF-1
SPC-699D-A565	Stressmarq	0.1mg	EUR 480
Description: A polyclonal antibody for IGF-1 from Human | Mouse. The antibody is produced in rabbit after immunization with human synthetic peptide from the mid-protein of Human IGF-1. The Antibody is tested and validated for WB, ICC/IF, IHC assays with the following recommended dilutions: WB (1:1000); ICC/IF (1:100); IHC (1:50). This IGF-1 antibody is conjugated to ATTO 565.

Antibody for Human IGF-1
SPC-699D-A594	Stressmarq	0.1mg	EUR 480
Description: A polyclonal antibody for IGF-1 from Human | Mouse. The antibody is produced in rabbit after immunization with human synthetic peptide from the mid-protein of Human IGF-1. The Antibody is tested and validated for WB, ICC/IF, IHC assays with the following recommended dilutions: WB (1:1000); ICC/IF (1:100); IHC (1:50). This IGF-1 antibody is conjugated to ATTO 594.

Antibody for Human IGF-1
SPC-699D-A633	Stressmarq	0.1mg	EUR 480
Description: A polyclonal antibody for IGF-1 from Human | Mouse. The antibody is produced in rabbit after immunization with human synthetic peptide from the mid-protein of Human IGF-1. The Antibody is tested and validated for WB, ICC/IF, IHC assays with the following recommended dilutions: WB (1:1000); ICC/IF (1:100); IHC (1:50). This IGF-1 antibody is conjugated to ATTO 633.

Antibody for Human IGF-1
SPC-699D-A655	Stressmarq	0.1mg	EUR 480
Description: A polyclonal antibody for IGF-1 from Human | Mouse. The antibody is produced in rabbit after immunization with human synthetic peptide from the mid-protein of Human IGF-1. The Antibody is tested and validated for WB, ICC/IF, IHC assays with the following recommended dilutions: WB (1:1000); ICC/IF (1:100); IHC (1:50). This IGF-1 antibody is conjugated to ATTO 655.

Antibody for Human IGF-1
SPC-699D-A680	Stressmarq	0.1mg	EUR 480
Description: A polyclonal antibody for IGF-1 from Human | Mouse. The antibody is produced in rabbit after immunization with human synthetic peptide from the mid-protein of Human IGF-1. The Antibody is tested and validated for WB, ICC/IF, IHC assays with the following recommended dilutions: WB (1:1000); ICC/IF (1:100); IHC (1:50). This IGF-1 antibody is conjugated to ATTO 680.

Antibody for Human IGF-1
SPC-699D-A700	Stressmarq	0.1mg	EUR 480
Description: A polyclonal antibody for IGF-1 from Human | Mouse. The antibody is produced in rabbit after immunization with human synthetic peptide from the mid-protein of Human IGF-1. The Antibody is tested and validated for WB, ICC/IF, IHC assays with the following recommended dilutions: WB (1:1000); ICC/IF (1:100); IHC (1:50). This IGF-1 antibody is conjugated to ATTO 700.

Antibody for Human IGF-1
SPC-699D-APC	Stressmarq	0.1mg	EUR 478.8
Description: A polyclonal antibody for IGF-1 from Human | Mouse. The antibody is produced in rabbit after immunization with human synthetic peptide from the mid-protein of Human IGF-1. The Antibody is tested and validated for WB, ICC/IF, IHC assays with the following recommended dilutions: WB (1:1000); ICC/IF (1:100); IHC (1:50). This IGF-1 antibody is conjugated to APC .

Antibody for Human IGF-1
SPC-699D-APCCY7	Stressmarq	0.1mg	EUR 565.2
Description: A polyclonal antibody for IGF-1 from Human | Mouse. The antibody is produced in rabbit after immunization with human synthetic peptide from the mid-protein of Human IGF-1. The Antibody is tested and validated for WB, ICC/IF, IHC assays with the following recommended dilutions: WB (1:1000); ICC/IF (1:100); IHC (1:50). This IGF-1 antibody is conjugated to APC/Cy7.

Antibody for Human IGF-1
SPC-699D-BI	Stressmarq	0.1mg	EUR 475.2
Description: A polyclonal antibody for IGF-1 from Human | Mouse. The antibody is produced in rabbit after immunization with human synthetic peptide from the mid-protein of Human IGF-1. The Antibody is tested and validated for WB, ICC/IF, IHC assays with the following recommended dilutions: WB (1:1000); ICC/IF (1:100); IHC (1:50). This IGF-1 antibody is conjugated to Biotin.

Antibody for Human IGF-1
SPC-699D-DY594	Stressmarq	0.1mg	EUR 474
Description: A polyclonal antibody for IGF-1 from Human | Mouse. The antibody is produced in rabbit after immunization with human synthetic peptide from the mid-protein of Human IGF-1. The Antibody is tested and validated for WB, ICC/IF, IHC assays with the following recommended dilutions: WB (1:1000); ICC/IF (1:100); IHC (1:50). This IGF-1 antibody is conjugated to Dylight 594.

Antibody for Human IGF-1
SPC-699D-DY633	Stressmarq	0.1mg	EUR 468
Description: A polyclonal antibody for IGF-1 from Human | Mouse. The antibody is produced in rabbit after immunization with human synthetic peptide from the mid-protein of Human IGF-1. The Antibody is tested and validated for WB, ICC/IF, IHC assays with the following recommended dilutions: WB (1:1000); ICC/IF (1:100); IHC (1:50). This IGF-1 antibody is conjugated to Dylight 633.

Antibody for Human IGF-1
SPC-699D-FITC	Stressmarq	0.1mg	EUR 470.4
Description: A polyclonal antibody for IGF-1 from Human | Mouse. The antibody is produced in rabbit after immunization with human synthetic peptide from the mid-protein of Human IGF-1. The Antibody is tested and validated for WB, ICC/IF, IHC assays with the following recommended dilutions: WB (1:1000); ICC/IF (1:100); IHC (1:50). This IGF-1 antibody is conjugated to FITC.

Antibody for Human IGF-1
SPC-699D-HRP	Stressmarq	0.1mg	EUR 465.6
Description: A polyclonal antibody for IGF-1 from Human | Mouse. The antibody is produced in rabbit after immunization with human synthetic peptide from the mid-protein of Human IGF-1. The Antibody is tested and validated for WB, ICC/IF, IHC assays with the following recommended dilutions: WB (1:1000); ICC/IF (1:100); IHC (1:50). This IGF-1 antibody is conjugated to HRP.

Antibody for Human IGF-1
SPC-699D-P594	Stressmarq	0.1mg	EUR 488.4
Description: A polyclonal antibody for IGF-1 from Human | Mouse. The antibody is produced in rabbit after immunization with human synthetic peptide from the mid-protein of Human IGF-1. The Antibody is tested and validated for WB, ICC/IF, IHC assays with the following recommended dilutions: WB (1:1000); ICC/IF (1:100); IHC (1:50). This IGF-1 antibody is conjugated to PE/ATTO 594.

Antibody for Human IGF-1
SPC-699D-PCP	Stressmarq	0.1mg	EUR 478.8
Description: A polyclonal antibody for IGF-1 from Human | Mouse. The antibody is produced in rabbit after immunization with human synthetic peptide from the mid-protein of Human IGF-1. The Antibody is tested and validated for WB, ICC/IF, IHC assays with the following recommended dilutions: WB (1:1000); ICC/IF (1:100); IHC (1:50). This IGF-1 antibody is conjugated to PerCP.

Antibody for Human IGF-1
SPC-699D-RPE	Stressmarq	0.1mg	EUR 476.4
Description: A polyclonal antibody for IGF-1 from Human | Mouse. The antibody is produced in rabbit after immunization with human synthetic peptide from the mid-protein of Human IGF-1. The Antibody is tested and validated for WB, ICC/IF, IHC assays with the following recommended dilutions: WB (1:1000); ICC/IF (1:100); IHC (1:50). This IGF-1 antibody is conjugated to RPE .

Antibody for Human IGF-1
SPC-699D-STR	Stressmarq	0.1mg	EUR 477.6
Description: A polyclonal antibody for IGF-1 from Human | Mouse. The antibody is produced in rabbit after immunization with human synthetic peptide from the mid-protein of Human IGF-1. The Antibody is tested and validated for WB, ICC/IF, IHC assays with the following recommended dilutions: WB (1:1000); ICC/IF (1:100); IHC (1:50). This IGF-1 antibody is conjugated to Streptavidin.

Antibody for Human IGF-1
SPC-699S	Stressmarq	0.012mg	EUR 78
Description: A polyclonal antibody for IGF-1 from Human | Mouse. The antibody is produced in rabbit after immunization with human synthetic peptide from the mid-protein of Human IGF-1. The Antibody is tested and validated for WB, ICC/IF, IHC assays with the following recommended dilutions: WB (1:1000); ICC/IF (1:100); IHC (1:50). This IGF-1 antibody is unconjugated.

Human Salivary IGF(salivary IGF) ELISA Kit
QY-E05383	Qayee Biotechnology	96T	EUR 433.2

Human IGF-1 LR3
SP-89927-100	Alpha Diagnostics	100 ug	EUR 270

Anti-Rat IGF-1 Antibody
5121-100	Biovision	each	EUR 379.2

Anti-Rat IGF-1 Antibody
5121-30T	Biovision	each	EUR 175.2

IGF-BP2, human recombinant
7165-10	Biovision	each	EUR 301.2

IGF-BP2, human recombinant
7165-50	Biovision	each	EUR 1123.2

IGF-BP7, human recombinant
7167-10	Biovision	each	EUR 248.4

IGF-BP7, human recombinant
7167-50	Biovision	each	EUR 810

IGF-BP6, human recombinant
7350-20	Biovision	each	EUR 444

IGF-BP1, human recombinant
4717-100	Biovision	each	EUR 744

IGF-BP1, human recombinant
4717-1000	Biovision	each	EUR 3778.8

IGF-BP1, human recombinant
4717-25	Biovision	each	EUR 307.2

IGF-BP3, human recombinant
4720-100	Biovision	each	EUR 744

IGF-BP3, human recombinant
4720-1000	Biovision	each	EUR 3778.8

IGF-BP3, human recombinant
4720-25	Biovision	each	EUR 307.2

IGF-BP5, human recombinant
4723-100	Biovision	each	EUR 744

IGF-BP5, human recombinant
4723-1000	Biovision	each	EUR 3778.8

IGF-BP5, human recombinant
4723-25	Biovision	each	EUR 307.2

Recombinant Human IGF-1
HEGFP-0901	Cyagen	100ug	Ask for price

Recombinant Human IGF-2
HEGFP-0908	Cyagen	10ug	Ask for price

Human IGF-I monoclonal antibody
MAM1	GroPep	500 µg	EUR 358.8

IGF-1, human recombinant
P1016-.02	ApexBio	20 µg	EUR 309.6
Description: Insulin-like growth factor I (IGF-1) is a polypeptide endocrine hormone structurally similar to insulin and is mainly produced in the liver when stimulated by growth hormone. IGF-1 is a growth factor that stimulates the proliferation of various cell types including muscle, bone, and cartilage tissue

IGF-1, human recombinant
P1016-.1	ApexBio	100 µg	EUR 915.6
Description: Insulin-like growth factor I (IGF-1) is a polypeptide endocrine hormone structurally similar to insulin and is mainly produced in the liver when stimulated by growth hormone. IGF-1 is a growth factor that stimulates the proliferation of various cell types including muscle, bone, and cartilage tissue

rec IGF-I (human)
H-5555.0050	Bachem	50.0µg	EUR 290.4
Description: CAS# [67763-96-6]

rec IGF-I (human)
H-5555.0100	Bachem	100.0µg	EUR 457.2
Description: CAS# [67763-96-6]

rec IGF-I (human)
H-5555.0500	Bachem	0.5mg	EUR 1720.8
Description: CAS# [67763-96-6]

Human IGF-I Protein
abx060791-100ug	Abbexa	100 ug	EUR 560.4

Biotinyl Human IGF-I
AQU010	GroPep	10 µg	EUR 303.6

Biotinyl Human IGF-I
AQU050	GroPep	50 µg	EUR 415.2

Biotinyl Human IGF-I
AQU100	GroPep	100 µg	EUR 637.2

Biotinyl Human IGF-I
AQU500	GroPep	500 µg	EUR 1305.6

Recombinant Human IGF-2/ IGF-II Protein, GST, E.coli-1mg
QP8601-ec-1mg	EnQuireBio	1mg	EUR 1958.4

Recombinant Human IGF-2/ IGF-II Protein, GST, E.coli-10ug
QP8601-ec-10ug	EnQuireBio	10ug	EUR 240

Recombinant Human IGF-2/ IGF-II Protein, GST, E.coli-50ug
QP8601-ec-50ug	EnQuireBio	50ug	EUR 315.6

Human [Ala31] IGF-I
AIU020	GroPep	20 µg	EUR 303.6

Human [Ala31] IGF-I
AIU100	GroPep	100 µg	EUR 415.2

Human [Leu60] IGF-I
ABU020	GroPep	20 µg	EUR 303.6

Human [Leu60] IGF-I
ABU100	GroPep	100 µg	EUR 415.2

Human [Arg6] IGF-II
GU020	GroPep	20 µg	EUR 303.6

Human [Leu24] IGF-I
ZU020	GroPep	20 µg	EUR 303.6

Human [Leu24] IGF-I
ZU100	GroPep	100 µg	EUR 415.2

Recombinant Human IGF-2/ IGF-II Protein, GST, E.coli-100ug
QP8601-ec-100ug	EnQuireBio	100ug	EUR 489.6

Recombinant Human IGF-2/ IGF-II Protein, GST, E.coli-200ug
QP8601-ec-200ug	EnQuireBio	200ug	EUR 760.8

Recombinant Human IGF-2/ IGF-II Protein, GST, E.coli-500ug
QP8601-ec-500ug	EnQuireBio	500ug	EUR 1272

Human [Leu27]IGF-II
TU100	GroPep	100 µg	EUR 415.2

Human IGF-2 ELISA Kit
EHI0307	Abclonal	96Tests	EUR 625.2

Human IGF-1 ELISA Kit
RK00160	Abclonal	96 Tests	EUR 625.2

Recombinant Human IGF-2/ IGF-II Protein, Untagged, E.coli-1mg
QP5264-1mg	EnQuireBio	1mg	EUR 1513.2

Recombinant Human IGF-2/ IGF-II Protein, Untagged, E.coli-10ug
QP5264-10ug	EnQuireBio	10ug	EUR 163.2

Recombinant Human IGF-2/ IGF-II Protein, Untagged, E.coli-50ug
QP5264-50ug	EnQuireBio	50ug	EUR 284.4

Recombinant Human IGF-2/ IGF-II Protein, Untagged, E.coli-100ug
QP5264-100ug	EnQuireBio	100ug	EUR 435.6

Recombinant Human IGF-2/ IGF-II Protein, Untagged, E.coli-500ug
QP5264-500ug	EnQuireBio	500ug	EUR 914.4

Recombinant Human IGF-BP1 Protein
PROTP08833-1	BosterBio	25ug	EUR 380.4
Description: IGF-BPs controls the distribution, function and activity of IGFs in various cell tissues and body fluids. Currently there are seven named IGF-BPs that form high affinity complexes with both IGF-I and IGF-II. IGF-BP1 is a 25.4 kDa cysteine-rich secreted protein expressed in liver, deciduas, and kidneys and is the most abundant IGF-BP in amniotic fluid. Levels of IGF-BP1 in serum are lowest after food. IGF-BP1 binds to both IGF-I and IGF-II with equal affinity. Phosphorylated IGF-BP1 hinders IGF actions, where as nonphosphorylated IGF-BP1 is stimulatory. Recombinant human IGF-BP1 is a 25.4 kDa protein consisting of 235 amino acid residues (Isoform A).

Recombinant Human IGF-BP3 Protein
PROTP17936-2	BosterBio	25ug	EUR 380.4
Description: IGF-BP3 is a 30 kDa cysteine-rich secreted protein. It is the major IGF binding protein present in the plasma of human and animals and it is also found in α-granules of platelets. In addition to its ability to modulate the activity of IGF-I and IGF-II, IGF-BP3 exerts inhibitory effects on follicle stimulating hormone (FSH) activity. Decreased plasma levels of IGF-BP3 often results in dwarfism, whereas elevated levels of IGF-BP3 may lead to acromegaly. The expression of IGF-BP3 in fibroblasts is stimulated by mitogenic growth factors such as Bombesin, Vasopressin, PDGF, and EGF. Recombinant human IGF-BP3 is a 28.8 kDa protein consisting of 264 amino acid residues.

Recombinant Human IGF-BP2 Protein
PROTP18065	BosterBio	20ug	EUR 380.4
Description: IGF-BPs controls the distribution, function and activity of IGFs in various cell tissues and body fluids. Currently there are seven named IGF-BPs that form high affinity complexes with both IGF-I and IGF-II. IGF-BP2 is a cysteine-rich secreted protein produced by bone cells, and is most abundant in the brain. IGF-BP2 has been shown to inhibit IGF-II action in human breast and ovarian carcinoma cells. Recombinant human IGF-BP2 is a 31.5 kDa protein consisting of 289 amino acid residues including the IGF-BP domain and thyroglobulin type-I domain. *Manufactured using (BTI-Tn-5B1-4) cells under license from the Boyce Thompson Institute for Plant Research, Inc.

Recombinant Human IGF-BP6 Protein
PROTP24592-2	BosterBio	20ug	EUR 380.4
Description: IGF-BPs controls the distribution, function and activity of IGFs in various cell tissues and body fluids. IGF-BP6 is produced by bone cells and is the major IGF-BP present in cerebrospinal fluid, and specifically inhibits IGF-II actions. IGF-BP6 has been shown to inhibit IGF-II-dependent cancers such as neuroblastoma, colon cancer and rhabdomyosarcoma. Recombinant human IGF-BP6 has a calculated mass of 22.6 kDa and consists of 213 amino acid residues including the IGF-BP domain and thyroglobulin type-I domain. IGF-BP6 migrates at an apparent molecular weight of approximately 23.0-30.0 kDa by SDS-PAGE analysis under non-reducing conditions. *Manufactured using (BTI-Tn-5B1-4) cells under license from the Boyce Thompson Institute for Plant Research, Inc.

Recombinant Human IGF-BP5 Protein
PROTP24593-1	BosterBio	25ug	EUR 380.4
Description: IGF-BPs controls the distribution, function and activity of IGFs in various cell tissues and body fluids. Currently there are seven named IGF-BPs that form high affinity complexes with both IGF-I and IGF-II. IGF-BP5 is a 28.6 kDa cysteine-rich secreted protein produced by vascular smooth muscle cells. It is the major IGF-binding protein present in bone tissue and helps potentiate the action of IGF-I on smooth muscle cells, fibroblasts or osteoblasts. Data shows that IGFBP-5 acts as a growth inhibitor and pro-apoptotic agent in breast cancer cells. IGFBP-5 overexpressing mice show an increase in neonatal mortality, reduced female fertility, whole-body growth inhibition and retarded muscle development. Recombinant human IGF-BP5 is a 28.6 kDa protein consisting of 253 amino acid residues.

Recombinant Human IGF-BP7 Protein
PROTQ16270-2	BosterBio	25ug	EUR 380.4
Description: IGF-BPs controls the distribution, function and activity of IGFs in various cell tissues and body fluids. Currently there are seven named IGF-BPs that form high affinity complexes with both IGF-I and IGF-II. IGF-BP7 is expressed in a wide range of normal human tissues and it generally shows reduced expression in cancer cell lines of prostate, breast, colon, and lung origin. It plays a role in skeletal myogenesis by binding to IGF in a manner that inhibits IGF induced differentiation of skeletal myoblasts, without affecting IGF induced proliferation. Additionally, IGF-BP7 suppresses growth and colony formation of prostate and breast cancer cell lines through an IGF independent mechanism, which causes a delay in the G1 phase of the cell cycle, and increased apoptosis. Recombinant human IGF-BP7 is a 26.4 kDa protein consisting of 256 amino acid residues.

IGF-1, DES1-3, human
RC216-12B	Bio Basic	100ug	EUR 203.56

IGF-1 (human) ELISA Kit
K4775-100	Biovision	100 assays	EUR 970.8
Description: Sensitive, Colorimetric Assay

IGF-1 ELISA KIT|Human
EF000135	Lifescience Market	96 Tests	EUR 826.8

IGF-2 ELISA KIT|Human
EF000742	Lifescience Market	96 Tests	EUR 826.8

IGF-I, human recombinant
4119-100	Biovision	each	EUR 210

IGF-I, human recombinant
4119-1000	Biovision	each	EUR 411.6

IGF-I, human recombinant
4119-10MG	Biovision	each	EUR 1834.8

IGF-I, human recombinant
4119-1G	Biovision	each	EUR 49388.4

IGF-I, human recombinant
4119-20MG	Biovision	each	EUR 2793.6

IGF-I, human recombinant
4119-5000	Biovision	each	EUR 1149.6

IGF-I, human recombinant
4119-50MG	Biovision	each	EUR 5064

Recombinant Human IGF-1, 15N
HEGFP-0902	Cyagen	10ug	Ask for price

Związek między poziomami alarmin w surowicy a wskaźnikami specyficznymi dla choroby u pacjentów z zapaleniem naczyń związanym z cytoplazmatycznymi przeciwciałami przeciw neutrofilom 

Background/purpose: We evaluated the connection between serum alarmin ranges and disease-specific indices in sufferers with anti-neutrophil cytoplasmic antibody (ANCA)-associated vasculitis (AAV).

Sufferers and strategies: Sera and information from 79 sufferers had been utilized. For AAV-specific indices, Birmingham vasculitis exercise rating (BVAS), five-factor rating (FFS), and vasculitis harm index (VDI) had been collected and serum ranges of 4 alarmins (hepatoma-derived progress issue, excessive mobility group field protein 1, S100A9, and S100A12) had been measured utilizing enzyme-linked immunosorbent assay. Associations between alarmin ranges, AAV-specific indices, and inflammatory laboratory markers had been assessed.

Outcomes: S100A9 ranges had been considerably correlated with C-reactive protein ranges (r=0.316, p=0.005) and S100A12 ranges correlated with VDI (r=0.232, p=0.040), which was constant in a subgroup of sufferers with myeloperoxidase (perinuclear)-ANCA positivity. No different associations had been discovered between alarmin ranges and BVAS, FFS, and VDI.

Conclusion: The serum S100A12 degree was related to organ harm in AAV, particularly in myeloperoxidase (perinuclear)-ANCA-positive sufferers.

Zapalenie skórno-mięśniowe z dodatnim przeciwciałem anty-MDA5 z szybko postępującą śródmiąższową chorobą płuc: opis dwóch przypadków

 Melanoma differentiation-associated protein 5 (MDA5) antibody-positive dermatomyositis (DM) shows distinctive cutaneous and pathologic options. We describe two circumstances of myositis-associated quickly progressive interstitial lung illness (RP-ILD).

The sufferers had been two girls from Kerala, India. Each sufferers had anti-MDA5 antibody-positive myositis. Each sufferers offered with RP-ILD with none scientific options of myositis and succumbed to their sickness regardless of aggressive medical therapy. Anti-MDA5-antibody-positive DM is characterised by amyopathic illness with quickly progressive and deadly ILD.

Charakterystyka przeciwciał monoklonalnych przeciw tężcowi jako pierwszy krok w kierunku opracowania testu immunologicznego na siłę szczepionki in vitro 

Batch launch testing for human and veterinary tetanus vaccines nonetheless depends closely on strategies that contain animals, notably for efficiency testing. The amount and high quality of tetanus antigen current in these merchandise is of utmost significance for product security and scientific impact. Immunochemical strategies that measure consistency of antigen content material and high quality, doubtlessly as an indicator of efficiency, may very well be a better option and negate the necessity for an in vivo efficiency check. These immunochemical strategies require at the least one nicely characterised monoclonal antibody (mAb) that’s particular for the goal antigen. On this paper we report the outcomes of the excellent characterisation of a panel of mAbs towards tetanus with a view to pick antibodies that can be utilized for improvement of an in vitro efficiency immunoassay.

We’ve assessed binding of the antibodies to native antigen (toxin), detoxified antigen (toxoid), adsorbed antigen and heat-altered antigen. Antibody perform was decided utilizing an in-house cell-based neutralisation assay to assist prior in vivo efficiency information that was obtainable for some, however not all, of the antibodies. As well as, antibody affinity was measured, and epitope competitors evaluation was carried out to establish pairs of antibodies that may very well be deployed in a sandwich immunoassay format. Not all characterisation assessments offered proof of “superiority” of 1 mAb over one other, however collectively the outcomes from all characterisation research allowed for choice of an antibody pair to be taken ahead to assay improvement.

Opis przypadku: autoimmunologiczne zapalenie mózgu związane z przeciwciałami dekarboksylazy kwasu przeciwglutaminowego: seria przypadków pediatrycznych

Background: Antibodies towards glutamic acid decarboxylase (GAD) are related to varied neurologic circumstances described in sufferers, together with stiff particular person syndrome, cerebellar ataxia, refractory epilepsy, and limbic and extralimbic encephalitis. There have been some case stories and investigations relating to anti-GAD65 antibody-associated encephalitis in grownup populations, however pediatric circumstances are uncommon. We retrospectively analyzed the scientific information of three anti-GAD65 antibody-positive sufferers to discover the range and scientific options of anti-GAD65 antibody-associated pediatric autoimmune encephalitis.

Strategies: The scientific information of a sequence of three sufferers optimistic for anti-GAD65 antibody had been retrospectively analyzed. GAD65 antibodies had been decided in serum and CSF utilizing a cell-based assay.

Outcomes: All three sufferers had been feminine, and the onset ages had been four years and 9 months, 6 years, and 16 years previous. Their scientific phenotypes included autoimmune limbic encephalitis, extralimbic encephalitis, and encephalitis combining limbic and extralimbic encephalitis. The scientific signs included seizures, reminiscence deficits, drowsiness, dysautonomia, and headache. All sufferers had irregular carinal MRI and EEG. All sufferers obtained immunotherapy and had transiently good responsiveness, however one affected person then skilled relapse. In follow-up, one affected person with extralimbic encephalitis recovered utterly, whereas two sufferers with limbic involvement had poor outcomes with refractory focal epilepsy.

Conclusion: Along with limbic encephalitis, extralimbic encephalitis can also be an necessary phenotype in sufferers who’re optimistic for anti-GAD65 antibodies. Early analysis and immunotherapy can enhance the signs. Nevertheless, sufferers with limbic encephalitis typically have refractory epilepsy within the continual section and have a poor long-term final result.

CXCL7 Recombinant Protein
92-388	ProSci	0.05 mg	EUR 437.1
Description: Human Chemokine (C-X-C motif) Ligand 7 (CXCL7), also known as neutrophil activating peptide 2 (NAP-2), is a member of the CXC chemokines containing an ELR domain (Glu-Leu-Arg tripeptide motif). Similar to other ELR domain containing CXC chemokines, such as IL-8 and the GRO proteins, CXCL7 binds CXCR2, chemoattracts and activates neutrophils. CXCL7, Connective Tissue Activating Protein III (CTAPIII) and beta thrombogulin ( beta TG), are proteolytically processed carboxylterminal fragments of platelet basic protein (PBP) which is found in the alphagranules of human platelets. Although CTAPIII, beta TG, and PBP represent amino-terminal extended variants of NAP2 and possess the same CXC chemokine domains, these proteins do not exhibit CXCL7/NAP2 activity. CXCL7 induces cell migration through the G-protein-linked receptor CXCR-2.

NAP-2 Antibody / CXCL7 / PPBP
RQ4113	NSJ Bioreagents	100 ug	EUR 356.15
Description: Chemokine (C-X-C motif) ligand 7 (CXCL7), also known as NAP2 or Pro-Platelet basic protein (PPBP), is a human gene. The protein encoded by this gene is a platelet-derived growth factor that belongs to the CXC chemokine family. This growth factor is a potent chemoattractant and activator of neutrophils. It has been shown to stimulate various cellular processes including DNA synthesis, mitosis, glycolysis, intracellular cAMP accumulation, prostaglandin E2 secretion, and synthesis of hyaluronic acid and sulfated glycosaminoglycan. It also stimulates the formation and secretion of plasminogen activator by synovial cells. Furthermore, the protein is an antimicrobial protein with bactericidal and antifungal activity.

NAP-2/CXCL7, Rat
HY-P7269	MedChemExpress	50ug	EUR 639.6

NAP-2, CXCL7, rat
RC352-18	Bio Basic	2ug	EUR 125.26

NAP-2/CXCL7, Human
HY-P7268	MedChemExpress	50ug	EUR 639.6

NAP-2, CXCL7, human
RC312-18	Bio Basic	2ug	EUR 125.26

Human CXCL7 ELISA Kit
LF-EK50893	Abfrontier	1×96T	EUR 777.6

CXCL7 ELISA KIT|Human
EF001450	Lifescience Market	96 Tests	EUR 826.8

ELISA kit for Mouse ?TG/PBP/CXCL7/NAP2 (Thromboglobulin, Beta)
E-EL-M1269	Elabscience Biotech	1 plate of 96 wells	EUR 640.8
Description: A sandwich ELISA kit for quantitative measurement of Mouse ?TG/PBP/CXCL7/NAP2 (Thromboglobulin, Beta) in samples from Serum, Plasma, Cell supernatant

Human CXCL7 Antibody (Biotin Conjugate)
32852-05121	AssayPro	150 ug	EUR 442.8

ELISA kit for Human CXCL7
EK5304	SAB	96 tests	EUR 663.6
Description: Enzyme-linked immunosorbent assay kit for quantification of Human CXCL7 in samples from serum, plasma, tissue homogenates and other biological fluids.

Recombinant Rat NAP-2/CXCL7
RECXP-0701	Cyagen	10ug	Ask for price

Human CXCL7 AssayLite Antibody (RPE Conjugate)
32852-05151	AssayPro	150 ug	EUR 513.6

Human CXCL7 AssayLite Antibody (APC Conjugate)
32852-05161	AssayPro	150 ug	EUR 513.6

Human CXCL7 AssayMax ELISA Kit
EC2270-1	AssayPro	96 Well Plate	EUR 572.4

Human CXCL7 PicoKine ELISA Kit
EK0729	BosterBio	96 wells	EUR 510
Description: For quantitative detection of human CXCL7 in cell culture supernates, cell lysates, serum and plasma (heparin, EDTA).

Human CXCL7 AssayLite Antibody (FITC Conjugate)
32852-05141	AssayPro	150 ug	EUR 513.6

Recombinant Human NAP-2 (CXCL7)
HECXP-0701	Cyagen	10ug	Ask for price

Human CXCL7 AssayLite Antibody (PerCP Conjugate)
32852-05171	AssayPro	150 ug	EUR 565.2

Neutrophil Activating Protein-2 (CXCL7) Antibody
20-abx137035	Abbexa	EUR 427.20 EUR 627.60	0.5 mg 1 mg

Nori® Canine CXCL7 ELISA Kit
GR115398	Genorise Scientific	96-well	EUR 461

Nori Equine CXCL7/NAP2 ELISA Kit
GR106909	Genorise Scientific	96-well	EUR 461

Rat PPBP/CXCL7 PicoKine ELISA Kit
EK0731	BosterBio	96 wells	EUR 510
Description: For Quantitative Detection of rat CXCL7 in cell culture supernates, serum and plasma (heparin, EDTA).

NAP-2/CXCL7 (CHO-expressed), Human
HY-P7267	MedChemExpress	50ug	EUR 596.4

Recombinant Human CXCL7/NAP-2 Protein
RP00829	Abclonal	10 μg	EUR 265.2

ThymusChemokine‑1/CXCL7 (CHO-expressed), Rat
HY-P7301	MedChemExpress	10ug	EUR 349.2

Nori® Human CXCL7-NAP2 ELISA Kit
GR106282	Genorise Scientific	96-well	EUR 461

Neutrophil Activating Protein-2 (CXCL7) Protein
20-abx261559	Abbexa	EUR 393.60 EUR 4101.60 EUR 276.00	10 ug 1 mg 2 µg

Neutrophil Activating Protein-2 (CXCL7) Protein
20-abx261561	Abbexa	EUR 393.60 EUR 4101.60 EUR 276.00	10 ug 1 mg 2 µg

Human CXCL7(Platelet basic protein) ELISA Kit
EH0007	FN Test	96T	EUR 681.12
Description: Method of detection: Double Antibody, Sandwich ELISA;Reacts with: Homo sapiens;Sensitivity: 9.375pg/ml

Rabbit Anti Mouse Cxcl1 Polyclonal Antibody
CPBT-65100RM	Creative Diagnostics	0.1 mg	EUR 1057.2

Human CXCL7 EZ-Set™ ELISA Kit (DIY Antibody Pairs)
EZ0729	BosterBio	5 plates/kit	EUR 321.6
Description: For the development of sandwich ELISA kit to measure human CXCL7 in cell culture supernates, cell lysates, tissue homogenates, serum and plasma (heparin, EDTA).

Recombinant Rat Neutrophil Activating Protein-2 (CXCL7)
7-02065	CHI Scientific	2µg	Ask for price

Recombinant Rat Neutrophil Activating Protein-2 (CXCL7)
7-02066	CHI Scientific	10µg	Ask for price

Recombinant Rat Neutrophil Activating Protein-2 (CXCL7)
7-02067	CHI Scientific	1mg	Ask for price

Rat Platelet Basic Protein / CXCL7 (PPBP) ELISA Kit
abx255841-96tests	Abbexa	96 tests	EUR 801.6

Pig Platelet Basic Protein / CXCL7 (PPBP) ELISA Kit
abx511493-96tests	Abbexa	96 tests	EUR 1093.2

Recombinant Human Neutrophil Activating Protein-2 (CXCL7)
7-02059	CHI Scientific	2µg	Ask for price

Recombinant Human Neutrophil Activating Protein-2 (CXCL7)
7-02060	CHI Scientific	10µg	Ask for price

Recombinant Human Neutrophil Activating Protein-2 (CXCL7)
7-02061	CHI Scientific	1mg	Ask for price

Human Platelet Basic Protein / CXCL7 (PPBP) ELISA Kit
abx252283-96tests	Abbexa	96 tests	EUR 801.6

Neutrophil Activating Protein-2 (CXCL7), 95 a.a. Protein
20-abx260678	Abbexa	EUR 393.60 EUR 4101.60 EUR 276.00	10 ug 1 mg 2 µg

Recombinant (E.Coli) Human Neutrophil Activating Protein-2 (CXCL7)
RP-1008	Alpha Diagnostics	10 ug	EUR 343.2

Human Thromboglobulin, Beta (bTG/PBP/CXCL7/NAP2) CLIA Kit
abx197774-96tests	Abbexa	96 tests	EUR 990

Mouse Anti-Human CXCL13 monoclonal antibody, clone JID662
CABT-L2832-100uL500uL	Creative Diagnostics	100 uL, 500 uL	EUR 602.4

Recombinant Human Neutrophil Activating Protein-2 (CXCL7), 95 a.a.
7-02062	CHI Scientific	2µg	Ask for price

Recombinant Human Neutrophil Activating Protein-2 (CXCL7), 95 a.a.
7-02063	CHI Scientific	10µg	Ask for price

Recombinant Human Neutrophil Activating Protein-2 (CXCL7), 95 a.a.
7-02064	CHI Scientific	1mg	Ask for price

ELISA kit for Rat ?TG/PBP/CXCL7/NAP2 (Thromboglobulin, Beta)
E-EL-R1087	Elabscience Biotech	1 plate of 96 wells	EUR 640.8
Description: A sandwich ELISA kit for quantitative measurement of Rat ?TG/PBP/CXCL7/NAP2 (Thromboglobulin, Beta) in samples from Serum, Plasma, Cell supernatant

ELISA kit for Human ?TG/PBP/CXCL7/NAP2 (Thromboglobulin, Beta)
E-EL-H1007	Elabscience Biotech	1 plate of 96 wells	EUR 640.8
Description: A sandwich ELISA kit for quantitative measurement of Human ?TG/PBP/CXCL7/NAP2 (Thromboglobulin, Beta) in samples from Plasma

Recombinant Human NAP-2/ PPBP/ CXCL7 Protein, GST, E.coli-1mg
QP8641-ec-1mg	EnQuireBio	1mg	EUR 1958.4

Recombinant Human NAP-2/ PPBP/ CXCL7 Protein, GST, E.coli-10ug
QP8641-ec-10ug	EnQuireBio	10ug	EUR 240

Recombinant Human NAP-2/ PPBP/ CXCL7 Protein, GST, E.coli-50ug
QP8641-ec-50ug	EnQuireBio	50ug	EUR 315.6

Recombinant Human NAP-2/ PPBP/ CXCL7 Protein, GST, E.coli-100ug
QP8641-ec-100ug	EnQuireBio	100ug	EUR 489.6

Recombinant Human NAP-2/ PPBP/ CXCL7 Protein, GST, E.coli-200ug
QP8641-ec-200ug	EnQuireBio	200ug	EUR 760.8

Recombinant Human NAP-2/ PPBP/ CXCL7 Protein, GST, E.coli-500ug
QP8641-ec-500ug	EnQuireBio	500ug	EUR 1272

Recombinant Rat NAP-2/ PPBP/ CXCL7 Protein, Untagged, E.coli-2ug
QP10285-ec-2ug	EnQuireBio	2ug	EUR 184.8

Recombinant Human C-X-C Motif Chemokine 7/CXCL7/NAP-2
C056-10ug	Novoprotein	10ug	EUR 242.4
Description: Lyophilized from a 0.2 μm filtered solution of 20mM PB, 150mM NaCl, pH 7.4.

Recombinant Human C-X-C Motif Chemokine 7/CXCL7/NAP-2
C056-1mg	Novoprotein	1mg	EUR 2739.6
Description: Lyophilized from a 0.2 μm filtered solution of 20mM PB, 150mM NaCl, pH 7.4.

Recombinant Human C-X-C Motif Chemokine 7/CXCL7/NAP-2
C056-500ug	Novoprotein	500ug	EUR 1935.6
Description: Lyophilized from a 0.2 μm filtered solution of 20mM PB, 150mM NaCl, pH 7.4.

Recombinant Human C-X-C Motif Chemokine 7/CXCL7/NAP-2
C056-50ug	Novoprotein	50ug	EUR 595.2
Description: Lyophilized from a 0.2 μm filtered solution of 20mM PB, 150mM NaCl, pH 7.4.

Recombinant Rat NAP-2/ PPBP/ CXCL7 Protein, Untagged, E.coli-10ug
QP10285-ec-10ug	EnQuireBio	10ug	EUR 348

Recombinant Human NAP-2/ PPBP/ CXCL7 Protein, Untagged, E.coli-2ug
QP10212-ec-2ug	EnQuireBio	2ug	EUR 184.8

Recombinant Rat NAP-2/ PPBP/ CXCL7 Protein, Untagged, E.coli-100ug
QP10285-ec-100ug	EnQuireBio	100ug	EUR 1413.6

Recombinant Rat NAP-2/ PPBP/ CXCL7 Protein, Untagged, E.coli-250ug
QP10285-ec-250ug	EnQuireBio	250ug	EUR 2480.4

Recombinant Human NAP-2/ PPBP/ CXCL7 Protein, Untagged, E.coli-10ug
QP10212-ec-10ug	EnQuireBio	10ug	EUR 348

Recombinant Human NAP-2/ PPBP/ CXCL7 Protein, Untagged, E.coli-100ug
QP10212-ec-100ug	EnQuireBio	100ug	EUR 1185.6

Recombinant Human NAP-2/ PPBP/ CXCL7 Protein, Untagged, E.coli-250ug
QP10212-ec-250ug	EnQuireBio	250ug	EUR 2077.2

Polyclonal (Mouse) Cxcl12 Antibody
APR10977G	Leading Biology	0.1ml	EUR 633.6
Description: A polyclonal antibody raised in Rabbit that recognizes and binds to Human (Mouse) Cxcl12 . This antibody is tested and proven to work in the following applications:

NAP-2 Neutrophil Activating Protein-2 Rat Recombinant Protein (CXCL7)
PROTQ99ME0	BosterBio	Regular: 10ug	EUR 380.4
Description: NAP-2 Rat Recombinant produced in E.coli is a single, non-glycosylated polypeptide chain containing 62 amino acids and having a molecular mass of 6.8kDa.;The NAP 2 is purified by proprietary chromatographic techniques.

NAP-2 Neutrophil Activating Protein-2 Human Recombinant Protein (CXCL7)
PROTP02775	BosterBio	Regular: 10ug	EUR 380.4
Description: Neutrophil Activating Protein-2 Human Recombinant produced in E.Coli is a non-glycosylated, Polypeptide chain containing 70 amino acids and having a molecular mass of 7609 Dalton. ;The NAP-2 is purified by proprietary chromatographic techniques.

CXCL16, Mouse
HY-P7151	MedChemExpress	10ug	EUR 321.6

Genorise® Mouse CXCL10 Polyclonal Antibody
GR131005	Genorise Scientific	100 µg	EUR 398

Mouse CXCL10 ELISA Kit
55R-1745	Fitzgerald	1 kit	EUR 781.2
Description: ELISA kit for detection of CXCL10 in the research laboratory

Mouse CXCL16 ELISA Kit
55R-1746	Fitzgerald	1 kit	EUR 781.2
Description: ELISA kit for detection of CXCL16 in the research laboratory

Mouse CXCL16 ELISA kit
55R-2086	Fitzgerald	96 tests	EUR 854.4
Description: ELISA Kit for detection of CXCL16 in the research laboratory

Mouse CXCL16 ELISA Kit
EMC0858	Abclonal	96Tests	EUR 625.2

Mouse CXCL16 ELISA kit
LF-EK50573	Abfrontier	1×96T	EUR 777.6

Mouse CXCL10 ELISA Kit
STJ150228	St John's Laboratory	1 kit	EUR 494.4
Description: The kit is a sandwich enzyme immunoassay for in vitro quantitative measurement of IP-10/CXCL10 in Mouse serum, plasma and other biological fluids

CXCL3, Mouse
HY-P7153	MedChemExpress	50ug	EUR 804

Recombinant Mouse CXCL16
7-01804	CHI Scientific	5µg	Ask for price

Recombinant Mouse CXCL16
7-01805	CHI Scientific	25µg	Ask for price

Recombinant Mouse CXCL16
7-01806	CHI Scientific	1mg	Ask for price

CXCL16, murine (mouse)
RC332-27	Bio Basic	5ug	EUR 125.26

IP-10/CXCL10, Mouse
HY-P7227	MedChemExpress	50ug	EUR 639.6

CXCL16 protein (mouse)
30R-AC078	Fitzgerald	25 ug	EUR 327.6
Description: Purified recombinant Mouse CXCL16 protein

Mouse CXCL13/BLC ELISA Kit
LF-EK50896	Abfrontier	1×96T	EUR 777.6

ELISA kit for Mouse CXCL16
EK5311	SAB	96 tests	EUR 663.6
Description: Enzyme-linked immunosorbent assay kit for quantification of Mouse CXCL16 in samples from serum, plasma, tissue homogenates and other biological fluids.

Mouse CXCL16 shRNA Plasmid
20-abx975400	Abbexa	EUR 961.20 EUR 1345.20	150 µg 300 µg

Mouse CXCL15 shRNA Plasmid
20-abx972610	Abbexa	EUR 961.20 EUR 1345.20	150 µg 300 µg